US 9643961
Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activities
granted A61KA61K31/4709A61P
Quick answer
US patent 9643961 (Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activities) held by Almirall, S.A. expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Almirall, S.A.
- Grant date
- Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/4709, A61P, A61P1/00, A61P1/06